Inventor · disambiguated record
Svend Treppendahl
Also filed as: TREPPENDAHL SVEND
26 granted patents·3 pending applications·389 citations·filing 1996–2018
96Inventor score
Top patents by PatentIndex Score
29 records- 0186US6043269Acis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromesNOVO NORDISK AS·Filed 1997·Granted Mar 28, 2000·38 cites·10 claims
- 0285US6316494B1cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromesNOVO NORDISK AS·Filed 1997·Granted Nov 13, 2001·36 cites·27 claims
- 0385US5985306A(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromesNOVO NORDISK AS·Filed 1997·Granted Nov 16, 1999·35 cites·26 claims
- 0484US9475748B2Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazineH LUNDBECK AS·Filed 2014·Granted Oct 25, 2016·4 cites·14 claims
- 0584US8940746B2Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazineTREPPENDAHL SVEND·Filed 2010·Granted Jan 27, 2015·7 cites·12 claims
- 0683US6110913AN-substituted azaheterocyclic carboxylic acids and esters thereofNOVO NORDISK AS·Filed 1998·Granted Aug 29, 2000·53 cites·41 claims
- 0782US5994390ATrans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromesNOVO NORDISK·Filed 1997·Granted Nov 30, 1999·30 cites·39 claims
- 0882US5919817ACis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromesNOVO NORDISK AS·Filed 1997·Granted Jul 6, 1999·28 cites·17 claims
- 0981US5958967ACis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromesNOVO NORDISK AS·Filed 1997·Granted Sep 28, 1999·26 cites·16 claims
- 1081US5859045ACrystalline -! 3R 4R-trans-7 methoxy 2,2-dimethyl1-3-phenyl 1-4 4-12 pyrrolidin-1 -Y1!ethoxyl 1!chromane hydrogen fumarateNOVO NORDISK AS·Filed 1997·Granted Jan 12, 1999·30 cites·7 claims
- 1175US6071901ASubstituted dibenz[b,f]azepines and uses thereofNOVO NORDISK AS·Filed 1998·Granted Jun 6, 2000·20 cites·31 claims
- 1273US10857149B2Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazineH LUNDBECK AS·Filed 2018·Granted Dec 8, 2020·0 cites·10 claims
- 1372US8901318B2Processes for the manufacture of a pharmaceutically active agentLUNDBECK & CO AS H·Filed 2013·Granted Dec 2, 2014·1 cites·9 claims
- 1470US8461353B2Processes for the manufacture of a pharmaceutically active agentTHERKELSEN FRANS·Filed 2010·Granted Jun 11, 2013·2 cites·7 claims
- 1568US6239148B1N-substituted azaheterocyclic carboxylic acids and esters thereofNOVO NORDISK AS·Filed 1998·Granted May 29, 2001·11 cites·10 claims
- 1667US5874428AN-substituted aza-heterocyclic carboxylic acids and esters thereofNOVO NORDISK ALS·Filed 1996·Granted Feb 23, 1999·26 cites·23 claims
- 1766US8501947B2Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazineTREPPENDAHL SVEND·Filed 2010·Granted Aug 6, 2013·1 cites·18 claims
- 1866US6569849B1N-Substituted azaheterocyclic compoundsNOVO NORDISK AS·Filed 1997·Granted May 27, 2003·24 cites·8 claims
- 1962US9382205B2Processes for the manufacture of a pharmaceutically active agentLUNDBECK & CO AS H·Filed 2014·Granted Jul 5, 2016·0 cites·19 claims
- 2062US6166009AN-substituted azaheterocyclic carboxylic acids and esters thereofNOVO NORDISK AS·Filed 1999·Granted Dec 26, 2000·7 cites·50 claims
- 2160US10034876B2Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazineH LUNDBECK AS·Filed 2016·Granted Jul 31, 2018·0 cites·10 claims
- 2259US5935987ATransdermal delivery of 3,4-diarylchromansNOVO NORDISK AS·Filed 1997·Granted Aug 10, 1999·8 cites·7 claims
- 2346US2012165325A1Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramideTREPPENDAHL SVEND·Filed 2012·Application pending·0 cites
- 2445US6613791B1N-substituted azaheterocyclic carboxylic acids and their useNOVO NORDISK AS·Filed 2000·Granted Sep 2, 2003·0 cites·19 claims
- 2544US2010286138A1Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramideLUNDBECK & CO AS H·Filed 2010·Application pending·0 cites
- 2643US5925771AProcess for the preparation of (-)-3,4-trans-diarylchromansNOVO NORDISK AS·Filed 1997·Granted Jul 20, 1999·2 cites·21 claims
- 2731US2001021710A1Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromesFiled 1997·Application pending·0 cites
- 2827US6372776B2Crystalline(−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleateNOVO NORDISK AS·Filed 1998·Granted Apr 16, 2002·0 cites·6 claims
- 2922US5834495ACrystalline xamoneline tartrateNOVO NORDISK AS·Filed 1996·Granted Nov 10, 1998·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Svend Treppendahl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →